Kinnevik (KINV) CMD 2024 summary
Event summary combining transcript, slides, and related documents.
CMD 2024 summary
19 Jan, 2026Strategic transformation and portfolio focus
Completed a seven-year transformation, reallocating from legacy assets to a concentrated portfolio in health and bio, software, and climate tech, with 96% of value in private companies.
Core portfolio now consists of five high-performing companies, representing over half of portfolio value, with average 60% growth in the last year and expected 40%+ in 2025.
Shifted geographic focus to Europe and the U.S., exited emerging markets, and narrowed sector focus, moving away from financial services, food, and marketplaces.
Three focus areas—Health & Bio, Software, and Climate Tech—represent 76% of portfolio value and 84% of investments since 2023.
Core companies include Cityblock, Mews, Pleo, Spring Health, and TravelPerk, all showing strong growth and profitability.
Financial guidance and capital allocation
Distributed SEK 88 billion to shareholders and invested nearly SEK 30 billion in new growth assets, maintaining a strong net cash position of SEK 12.2 billion as of Q3 2024.
Plans to invest SEK 15–20 billion through 2030, with a slight bias toward follow-on investments, and expects to release SEK 5–10 billion from the portfolio via M&A, secondary sales, and IPOs.
Anticipates at least three IPOs, aiming for 10 core companies to represent 80% of portfolio value, with 20–40% in public markets.
Targets 15%+ annual returns from the mature portfolio and 25%+ IRR for new investments, maintaining a net cash position and introducing share buybacks as a capital allocation tool.
Over 90% of 2025 follow-on investments expected to be allocated to core companies and new ventures.
Business developments and competitive advantages
Led funding rounds in core companies at balanced valuations, with all core companies profitable or funded to break-even.
Deployed SEK 2.5 billion into secondary transactions during 2023–24, capitalizing on liquidity needs of other investors.
Portfolio derisked through disciplined capital reallocation and a mark-to-market approach, with most holdings now performing or stable.
Permanent capital structure and long-term partnership model attract top founders and enable patient, hands-on ownership.
Deep sector expertise and founder alignment have made the firm a preferred investor in its focus areas.
Latest events from Kinnevik
- NAV fell 4% in Q4 and 8% for 2025 as market headwinds offset strong core company growth.KINV
Q4 20253 Feb 2026 - NAV fell 4.7–5% as core growth companies outperformed and capital deployment set to rise.KINV
Q2 20243 Feb 2026 - Strong portfolio growth offset by 15–20% valuation headwinds from market and currency shifts.KINV
Pre-silent presentation26 Jan 2026 - NAV fell 5% to SEK 37.4bn as VillageMD was written down, but core assets grew over 60%.KINV
Q3 202419 Jan 2026 - NAV up 5% to SEK 39.2bn, core companies grew 55%, strong SEK 10.9bn net cash for growth.KINV
Q4 20249 Jan 2026 - NAV up 2% to SEK 36.8bn, core revenue growth >35%, SEK 860m invested, SEK 9.6bn net cash.KINV
Q2 20258 Jan 2026 - NAV down 8% as core companies delivered >40% revenue growth and strong cash position.KINV
Q1 202524 Dec 2025 - NAV up 2% to SEK 37.5bn, with strong core growth and SEK 8.6bn net cash.KINV
Q3 202521 Oct 2025 - Q3 2025 featured higher investment activity and selective portfolio growth amid mild valuation declines.KINV
Pre-Silent Presentation2 Oct 2025